Streetbeat News

Stock Prices

LPG

Dorian LPG shares are trading lower following the company's announcement of a public offering of common shares.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:08 am

SMTC

Semtech shares are trading higher after the company reported better-than-expected Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:08 am

CXM

Sprinklr shares are trading lower after the company cut its FY25 guidance.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:07 am

FIVE

Five Below shares are trading lower after the company reported worse-than-expected Q1 earnings and cut its guidance.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:07 am

LULU

Lululemon shares are trading higher following the company's better-than-expected Q1 financial results and the authorization of a $1 billion increase in its stock repurchase program.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:06 am

HOFT

Hooker Furnishings anticipates short-term volatility in earnings due to an industry-wide downturn.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:05 am

HOFT

Hooker Furnishings (NASDAQ:HOFT) reported a significant quarterly loss of $(0.39) per share, missing the analyst consensus estimate of $(0.03) by a wide margin. The company's sales also fell short of expectations, reporting $93.571 million against the estimated $94.941 million. Both earnings and sales have seen a substantial decline compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 10:01 am

APLD

CXM

FIVE

LPG

MASI

NKLA

SMMT

ZIM

Several major stocks, including Five Below, Sprinklr, Masimo, Dorian LPG, Nikola, ZIM Integrated Shipping Services, Summit Therapeutics, and Applied Digital, experienced significant declines in pre-market trading. Five Below posted weak Q1 results and lowered its FY guidance, leading to a sharp drop in its stock price.

Portfolio Pulse from Avi Kapoor

June 06, 2024 | 9:40 am

GILD

Gilead Sciences' Phase 2B MYR204 study showed promising results for Bulevirtide combined with Pegylated Interferon Alfa-2A in treating compensated chronic Hepatitis Delta Virus. 46% of patients achieved undetectable HDV RNA at week 24 post-treatment.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 9:23 am

EWU

The S&P Global / CIPS U.K. Construction Purchasing Managers Index (PMI) for May came in at 54.7, surpassing the estimated 52.5 and the previous month's 53.0. This indicates a stronger-than-expected performance in the U.K. construction sector.

Portfolio Pulse from Benzinga Newsdesk

June 06, 2024 | 9:16 am